PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)
Titel:
PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)
Auteur:
Van Cutsem, E. Ciardiello, F. Ychou, M. Seitz, J.-F. Hofheinz, R. Arriaga, Y. Garcia-Carbonero, R. Grothey, A. Miriyala, A. Kalmus, J. Kappeler, C. Falcone, A. Zaniboni, A.